Table 2.
Waiting Time, Organ-Specific Disease Score, Post-Transplant Length of Stay, and Post-Transplant Survival Stratified by Organ Type and Insurance Group.
| Variable | Total | Private | Medicare | Medicaid | p Value |
|---|---|---|---|---|---|
| Heart, n | 17,239 | 9,925 | 5,157 | 2,157 | |
| Waiting time, d, median (IQR) | 78 (23–223) | 75 (23– 209) |
91 (27–271) | 66 (20–181) | <.001 |
| Status at Tx, n (%) | |||||
| Status 1A | 7,495 (43.5) | 4,394 (44.3) |
2,090 (40.6) | 1,011 (46.9) | <.001 |
| Status 1B | 6,778 (39.3) | 3,789 (38.2) |
2,134 (41.4) | 855 (39.7) | |
| Status 2 | 2,960 (17.2) | 1,741 (17.5) |
930 (18.0) | 289 (13.4) | |
| Postop length of stay, d, median (IQR) |
14 (10–21) | 13 (10–20) | 14 (10–22) | 15 (10–22) | <.001 |
| Follow-up time, y, median (IQR) |
3.9 (1.8–5.0) | 4.0 (1.9– 5.0) |
3.1 (1.1–5.0) | 3.8 (1.8–5.0) | <.001 |
| 5-year survival, %* | 74.3 | 77.2 | 71.1 | 67.9 | <.001 |
| Lung, n | 13,206 | 7,964 | 4,271 | 971 | |
| Waiting time, d, median (IQR) | 107 (29–329.5) | 108 (30– 325.5) |
106 (28– 342.5) |
105.5 (31– 331) |
0.8 |
| LAS at Tx†, median (IQR) | 39.1 (34–48) | 39.6 (35– 49) |
38.1 (34–47) | 39.1 (34–49) | <.001 |
| Postop length of stay, d, median (IQR) |
15 (10–26) | 15 (10– 25) |
15 (10–26) | 17 (12–28) | <.001 |
| Follow-up time, y, median (IQR) |
2.7 (1.0–5.0) | 2.9 (1.1– 5.0) |
2.1 (1.0–4.3) | 2.3 (1.0–4.6) | <.001 |
| 5-year survival, %* | 52.0 | 54.9 | 47.6 | 45.0 | <.001 |
| Liver, n | 48,201 | 30,941 | 10,158 | 7,102 | |
| Waiting time, d, median (IQR) | 72 (15–256) | 71 (14– 248) |
90 (20–331) | 51 (10–203) | <.001 |
| MELD at Tx, median (IQR) | 19 (14–27) | 19 (13–27) | 18 (13–25) | 21 (15–30) | <.001 |
| Postop length of stay, d, median (IQR) |
10 (7–17) | 10 (7–16) | 10 (7–18) | 11 (8–19) | <.001 |
| Follow-up time, y, median (IQR) |
3.1 (1.1–5.0) | 3.5 (1.3– 5.0) |
3.0 (1.0–5.0) | 3.0 (1.1–5.0) | <.001 |
| 5-year survival, %* | 70.1 | 72.3 | 64.8 | 67.6 | <.001 |
| Renal, n | 90,548 | 25,970 | 60,217 | 4,361 | |
| Waiting time, d, median (IQR) | 704 (302–1222) | 527 (223– 956) |
778 (351– 1314) |
799 (326– 1441) |
<.001 |
| Dialysis time, y, median (IQR) | 3.2 (1.5–5.2) | 1.8 (0.5– 3.1) |
3.8 (2.2–5.7) | 3.9 (1.9–6.4) | <.001 |
| Postop length of stay, d, median (IQR) |
6 (5–9) | 5 (4–8) | 6 (5–9) | 6 (5–9) | <.001 |
| Follow-up time, y, median (IQR) |
3.7 (1.9–5.0) | 4.0 (2.0– 5.0) |
3.4 (1.8–5.0) | 3.8 (1.9–5.0) | <.001 |
| 5-year survival, %* | 80.2 | 84.6 | 78.0 | 82.9 | <.001 |
*
Estimated 5-year survival (unadjusted) calculated via Kaplan Meier methods and compared using Log Rank test
†
LAS missing for 50% prior to implementation in 2006
Tx, transplant; IQR, interquartile range; LAS, lung allocation score; MELD, Model for End-Stage Liver Disease